Violation Tracker Individual Record

Company: 
Schwarz Pharma Inc.
Current Parent Company: 
UCB
Penalty: 
$22,000,000
Year: 
2010
Date: 
April 29, 2010
Offense Group: 
government-contracting-related offenses
Primary Offense: 
False Claims Act and related
Secondary Offense: 
off-label or unapproved promotion of medical products
Violation Description: 

Schwarz Pharma Inc. agreed to pay $22 million to resolve False Claims Act allegations that the company failed to advise the Centers for Medicare and Medicaid Services that two unapproved products did not qualify for coverage under federal health care programs. Schwarz was alleged to have submitted false quarterly reports to the government related to a pair of drugs, Deponit and Hyoscyamine Sulfate Extended Release.

Level of Government: 
federal
Action Type: 
agency action
Agency: 
Justice Department Civil Division
Civil or Criminal Case: 
civil
HQ Country of Parent: 
Belgium
Ownership Structure of Parent: 
publicly traded
Major Industry of Parent: 
pharmaceuticals
Specific Industry of Parent: 
pharmaceuticals
Source Notes: 
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note: 
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.